Related references
Note: Only part of the references are listed.Prevalence of Synthetic Cannabinoids in US Athletes: Initial Findings
Rebecca Heltsley et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2012)
Here Today, Gone Tomorrow...and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines
Christopher D. Rosenbaum et al.
JOURNAL OF MEDICAL TOXICOLOGY (2012)
Severe Toxicity Following Synthetic Cannabinoid Ingestion
J. Lapoint et al.
CLINICAL TOXICOLOGY (2011)
Synthetic cannabinoid JWH-018 and psychosis: An explorative study
Susanna Every-Palmer
DRUG AND ALCOHOL DEPENDENCE (2011)
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
Arshid Mir et al.
PEDIATRICS (2011)
Beyond THC: the new generation of cannabinoid designer drugs
Liana Fattore et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2011)
Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes
JW Huffman et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Marijuana withdrawal in humans: Effects of oral THC or divalproex
M Haney et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2
MD Aceto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding
MM Aung et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Share Paper
